-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QUZ/UksbUkjsV2VNF0YCcHKK+UPsNo2XdRXY1vJjlUExQP9ZElEWPwLShgKrkl5k 3z4RSIjXvOtbN0cM5t+lxw== 0001181431-07-073676.txt : 20071206 0001181431-07-073676.hdr.sgml : 20071206 20071206163322 ACCESSION NUMBER: 0001181431-07-073676 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20071203 ITEM INFORMATION: Other Events FILED AS OF DATE: 20071206 DATE AS OF CHANGE: 20071206 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EnteroMedics Inc CENTRAL INDEX KEY: 0001371217 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33818 FILM NUMBER: 071289846 BUSINESS ADDRESS: STREET 1: 2800 Patton Rd CITY: St Paul STATE: MN ZIP: 55113 MAIL ADDRESS: STREET 1: 2800 Patton Rd CITY: St Paul STATE: MN ZIP: 55113 8-K 1 rrd180954.htm FORM 8-K RE OVERALLOTMENT EXERCISE Prepared By R.R. Donnelley Financial -- Form 8-K
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 8-K
 
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported):  12/03/2007
 
EnteroMedics Inc.
(Exact name of registrant as specified in its charter)
 
Commission File Number:  001-33818
 
Delaware
  
48-1293684
(State or other jurisdiction of
  
(IRS Employer
incorporation)
  
Identification No.)
 
2800 Patton Road
St. Paul, MN 55113
(Address of principal executive offices, including zip code)
 
651-634-3003
(Registrant’s telephone number, including area code)
 
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[  ]   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[  ]   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[  ]   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[  ]   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 

 
Item 8.01.    Other Events
 
On December 3, 2007, the underwriters of EnteroMedics Inc.'s (the "Company") recent initial public offering of 5,000,000 shares of common stock registered on the Company's Registration Statement on Form S-1 (File No. 333-143265) partially exercised an over-allotment option granted in connection with the offering and purchased an additional 489,849 shares of the Company's common stock at $8.00 per share. After deducting all underwriting discounts, commissions and fees, the Company received net proceeds of $3,644,476.56 at the closing of the over-allotment option on December 6, 2007. J.P. Morgan Securities Inc. and Morgan Stanley & Co. Incorporated have acted as joint book-running managers, Cowen and Company, LLC has acted as co-lead and Leerink Swann LLC has acted as co-manager for the offering.
 

 

Signature(s)
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
      
 
EnteroMedics Inc.
 
 
Date: December 06, 2007
     
By:
 
/s/    Greg S. Lea
               
Greg S. Lea
               
Senior Vice President and Chief Financial Officer
 
 
 -----END PRIVACY-ENHANCED MESSAGE-----